Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125932821 | 12593282 | 1 | I | 20100315 | 20160201 | 20160726 | 20160726 | PER | US-ABBVIE-16P-163-1551506-00 | ABBVIE | 44.55 | YR | F | Y | 0.00000 | 20160726 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125932821 | 12593282 | 1 | PS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 137MCG SUN., TUES. THURSDAY., SAT | N | UNKNOWN | 21402 | ||||||||
125932821 | 12593282 | 2 | SS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 84661247 | N | UNKNOWN | 21402 | QD | |||||||
125932821 | 12593282 | 3 | SS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | MON, WED, AND FRIDAYS | N | 21402 | |||||||||
125932821 | 12593282 | 4 | SS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | MON, WED, AND FRIDAYS | N | 21402 | |||||||||
125932821 | 12593282 | 5 | C | MYRBETRIQ | MIRABEGRON | 1 | Oral | 0 | 50 | MG | TABLET | ||||||||
125932821 | 12593282 | 6 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Unknown | EXTENDED RELEASE | 0 | 100 | MG | QD | |||||||
125932821 | 12593282 | 7 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 0 | 10 | MG | TABLET | ||||||||
125932821 | 12593282 | 8 | C | ASTEPRO | AZELASTINE HYDROCHLORIDE | 1 | Unknown | 2 SPRAYS PER NOSTRIL | 0 | .15 | PCT | QD | |||||||
125932821 | 12593282 | 9 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Sublingual | 0 | 1 | DF | QD | ||||||||
125932821 | 12593282 | 10 | C | BEANO | ASPERGILLUS NIGER .ALPHA.-GALACTOSIDASE | 1 | Unknown | A DAY BEFORE MEALS (CEGTABLES/GRAINS) | 0 | 2 | DF | TID | |||||||
125932821 | 12593282 | 11 | C | CITRACAL + D | CALCIUM CITRATEVITAMIN D | 1 | Unknown | 0 | 1 | DF | TABLET | BID | |||||||
125932821 | 12593282 | 12 | C | COLACE | DOCUSATE SODIUM | 1 | Unknown | SOFT GEL CAPSULE | 0 | 100 | MG | CAPSULE | BID | ||||||
125932821 | 12593282 | 13 | C | DIAZEPAM. | DIAZEPAM | 1 | Unknown | 1-2 TIMES A DAY, NOT TO EXCEED 10MG DIALY | 0 | 1 | DF | TABLET | |||||||
125932821 | 12593282 | 14 | C | FLUOCINONIDE. | FLUOCINONIDE | 1 | Topical | SMALL AMOUNT | 0 | CREAM | |||||||||
125932821 | 12593282 | 15 | C | GAS-X | DIMETHICONE | 1 | Unknown | 0 | 2 | DF | TABLET | ||||||||
125932821 | 12593282 | 16 | C | GAS-X | DIMETHICONE | 1 | 0 | ||||||||||||
125932821 | 12593282 | 17 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | 0 | 100 | MG | |||||||||
125932821 | 12593282 | 18 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | 0 | ||||||||||||
125932821 | 12593282 | 19 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | 0 | ||||||||||||
125932821 | 12593282 | 20 | C | MAXALT | RIZATRIPTAN BENZOATE | 1 | Unknown | AT ONSET OF HEADACHE, REPEAT ONCE IN 2 HOURS | 0 | 10 | MG | TABLET | |||||||
125932821 | 12593282 | 21 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | 0 | 1 | DF | TABLET | BID | |||||||
125932821 | 12593282 | 22 | C | MOBIC | MELOXICAM | 1 | Unknown | 0 | 7.5 | MG | TABLET | BID | |||||||
125932821 | 12593282 | 23 | C | METAMUCIL | PLANTAGO SEED | 1 | Oral | 2 TABLESPOONS WITH 1/2 CUP LIQUID | 0 | BID | |||||||||
125932821 | 12593282 | 24 | C | NASONEX | MOMETASONE FUROATE | 1 | Respiratory (inhalation) | 2 SPRAYS IN EACH NOSTRIL MORNING | 0 | 50 | UG | NASAL SPRAY | QD | ||||||
125932821 | 12593282 | 25 | C | NASONEX | MOMETASONE FUROATE | 1 | 0 | ||||||||||||
125932821 | 12593282 | 26 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Unknown | DELAYED RELEASE, BEFORE MEALS | 0 | 1 | DF | TABLET | QD | ||||||
125932821 | 12593282 | 27 | C | OXYBUTYNIN CHLORIDE. | OXYBUTYNIN CHLORIDE | 1 | Unknown | 0 | 1 | DF | TABLET | QD | |||||||
125932821 | 12593282 | 28 | C | ROPINIROLE HCL | ROPINIROLE HYDROCHLORIDE | 1 | Unknown | 0 | 1 | DF | TABLET | ||||||||
125932821 | 12593282 | 29 | C | SINUS RINSE | SODIUM BICARBONATESODIUM CHLORIDE | 1 | Unknown | 1-2 TIMES A DAY (IN PLACE OF NASAL SPRAY) | 0 | ||||||||||
125932821 | 12593282 | 30 | C | TOPAMAX | TOPIRAMATE | 1 | 3 IN THE MORNING AND 3 AT NIGHT, DAILY | 0 | 75 | MG | |||||||||
125932821 | 12593282 | 31 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | 1-3 TABLETS A DAY FOR NOW | 0 | 50 | MG | TABLET | |||||||
125932821 | 12593282 | 32 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | AFTER HEALING, EVERY 6 HOURS DUE TO FALLS/ INJURIES | 0 | 2 | DF | TABLET | |||||||
125932821 | 12593282 | 33 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 0 | 2 | DF | CAPSULE | QD | |||||||
125932821 | 12593282 | 34 | C | ZYRTEC-D | CETIRIZINE HYDROCHLORIDEPSEUDOEPHEDRINE HYDROCHLORIDE | 1 | Unknown | 1 TO 2 TABLETS | 0 | TABLET | |||||||||
125932821 | 12593282 | 35 | C | HALOBETASOL PROPIONATE. | HALOBETASOL PROPIONATE | 1 | Topical | 0 | CREAM | ||||||||||
125932821 | 12593282 | 36 | C | TETRIX | 2 | Topical | SMALL AMOUNT | 0 | CREAM |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125932821 | 12593282 | 1 | Hypothyroidism |
125932821 | 12593282 | 3 | Hypothyroidism |
125932821 | 12593282 | 5 | Product used for unknown indication |
125932821 | 12593282 | 6 | Depression |
125932821 | 12593282 | 7 | Product used for unknown indication |
125932821 | 12593282 | 8 | Sinus disorder |
125932821 | 12593282 | 9 | Product used for unknown indication |
125932821 | 12593282 | 10 | Dyspepsia |
125932821 | 12593282 | 11 | Osteoporosis |
125932821 | 12593282 | 12 | Constipation prophylaxis |
125932821 | 12593282 | 13 | Anxiety |
125932821 | 12593282 | 14 | Pruritus |
125932821 | 12593282 | 15 | Dyspepsia |
125932821 | 12593282 | 16 | Flatulence |
125932821 | 12593282 | 17 | Anger |
125932821 | 12593282 | 18 | Aggression |
125932821 | 12593282 | 19 | Depression |
125932821 | 12593282 | 20 | Migraine |
125932821 | 12593282 | 21 | Product used for unknown indication |
125932821 | 12593282 | 22 | Antiinflammatory therapy |
125932821 | 12593282 | 23 | Constipation prophylaxis |
125932821 | 12593282 | 24 | Sinus disorder |
125932821 | 12593282 | 25 | Hypersensitivity |
125932821 | 12593282 | 26 | Dyspepsia |
125932821 | 12593282 | 27 | Incontinence |
125932821 | 12593282 | 28 | Muscle spasms |
125932821 | 12593282 | 29 | Sinus disorder |
125932821 | 12593282 | 30 | Migraine |
125932821 | 12593282 | 31 | Back pain |
125932821 | 12593282 | 33 | Vitamin D decreased |
125932821 | 12593282 | 34 | Sinus disorder |
125932821 | 12593282 | 35 | Rash |
125932821 | 12593282 | 36 | Rash |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125932821 | 12593282 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125932821 | 12593282 | 1 | 20100312 | 20100318 | 0 | |
125932821 | 12593282 | 2 | 20100326 | 0 | ||
125932821 | 12593282 | 3 | 20100312 | 20100318 | 0 | |
125932821 | 12593282 | 4 | 20100326 | 0 | ||
125932821 | 12593282 | 30 | 20091110 | 0 | ||
125932821 | 12593282 | 31 | 20151011 | 0 | ||
125932821 | 12593282 | 32 | 20151219 | 0 | ||
125932821 | 12593282 | 34 | 20091121 | 0 |